The Pregnancy and Postpartum Mental Health Optimization Virtual Intervention Network
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorWomen's College Hospital
About this trial
Depression, anxiety, and related disorders such as post-traumatic stress and obsessive compulsive disorder affect about 20% of pregnant and postpartum people. When not treated properly, these issues negatively impact not only affected people, but also their children's health and development. Only 1 in 5 receive adequate treatment, so identifying new system-wide approaches to reliably deliver recommended care to perinatal mental health patients all is a crucial health care priority. The Pregnancy and Postpartum Mental health Optimization Virtual Intervention Network (MOVIN) is a scalable perinatal mental health platform building on the evidence-based Collaborative care delivery model. MOVIN's online platform allows patients to connect with a care coordinator to co-develop personalized treatment recommendations, in collaboration with their primary care clinician and a perinatal psychiatrist when needed; progress is tracked to re-evaluate.
Eligibility criteria
Qualifiers
Adult (age 18 years or older)
Pregnant or postpartum and living with their infant 0-6 months old. This includes all individuals who identify as women, as well as those of female sex who do not identify as women (e.g., non-binary, trans) who are the primary parent for their infant. This includes via natural birth, adoption, or surrogacy.
EPDS score >10 at eligibility screening.
Disqualifiers
Active alcohol or substance use disorder, mania or psychotic disorder (as these conditions are better managed in direct specialty care).
Active suicide plan or intent (as emergent hospital-based care is likely required),
Plan to move out of Ontario during the study.
Unable to complete relevant study procedures and measures online. For the few participants without access to devices/home internet, we will budget for tablets/data plans.
Trial design
Treatments tested in this trial
- Enhanced Usual Care
- MOVIN Care Platform
- Enhanced Usual Care
Treatment groups
570 Participants
are divided into 2 treatment groupsSponsors and collaborators
Women's College Hospital
Lead sponsor
Sunnybrook Health Sciences Centre
Collaborator
Mount Sinai Hospital, Canada
Collaborator
The Ottawa Hospital
Collaborator
St. Joseph's Healthcare Hamilton
Collaborator
Source ClinicalTrials.gov